34 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... #Meningitis #Antibiotics ... InfectiousDiseases #Pharmacology ... #Management
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
therapy in bacterial meningitis ... #IDSA #Meningitis ... InfectiousDiseases #Pharmacology ... #Management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
#pharmacology #comparison ... #cardiology #gi ... #medications #management
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Thiazide #CHF #Cardiology ... #Management
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
Here is a quick ... chronic hepatitis C virus ... HepC #HepatitisC #Management ... #Pharmacology
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
pneumococcal resistance is ... fluoroquinolone #IDSA ... Treatment #Regimen #Management ... #Guidelines #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
SARS-CoV-2, the virus ... chloroquine/HCQ), here is ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management